Abdominal ultrasound → Anticipated
💠 Ultrasound is the diagnostic test of choice to identify placental location.
💠 It is noninvasive and safe in the setting of antepartum bleeding.
💠 Required before any cervical or vaginal examination.
💠 Helps confirm or rule out placenta previa vs abruption.
💠 Guides further management and delivery planning.
Administration of IV fluids → Anticipated
💠 Ongoing bleeding places the client at risk for hypovolemia.
💠 IV fluids support circulatory volume and uteroplacental perfusion.
💠 Prevents progression to maternal shock.
💠 Allows rapid access if blood products are needed.
💠 This is standard supportive care in antepartum bleeding.
Administration of betamethasone → Anticipated
💠 Client is 30 weeks gestation, at risk for preterm delivery.
💠 Betamethasone promotes fetal lung maturity.
💠 Recommended when preterm birth is a possibility within 7 days.
💠 Reduces neonatal RDS, IVH, and NEC.
💠 Appropriate even while awaiting definitive diagnosis.
Laboratory testing: CBC, Blood Type & Rh, Coagulation Studies → Anticipated
💠 CBC evaluates hemoglobin/hematocrit for blood loss.
💠 Blood type & Rh needed for possible transfusion and Rh-Ig if Rh-negative.
💠 Coagulation studies assess for bleeding complications.
💠 Establishes baseline values for ongoing monitoring.
💠 Standard of care in significant antepartum bleeding.
Digital cervical exam to assess dilation and effacement → Contraindicated
💠 Absolutely contraindicated with suspected placenta previa.
💠 Digital exam can disrupt placental attachment.
💠 May cause massive hemorrhage.
💠 Cervical assessment is deferred until placenta location is confirmed.
💠 This is a high-risk, unsafe intervention in this scenario.
Placement of an internal fetal spiral electrode → Contraindicated
💠 Requires ruptured membranes and cervical dilation.
💠 Invasive and increases risk of hemorrhage and infection.
💠 Contraindicated with antepartum bleeding of unknown cause.
💠 External monitoring is sufficient and safer.
💠 Should not be used until placenta previa is ruled out.
Continuous monitoring of FHR → Anticipated
💠 Ongoing bleeding places fetus at risk for hypoxia.
💠 Continuous monitoring evaluates fetal well-being in real time.
💠 Allows early detection of fetal distress.
💠 Noninvasive and safe.
💠 Standard intervention in antepartum hemorrhage